Notice: Passwords are now case-sensitive
Forgot your password? Register a new account

Connections

Groups

Community Requests

Oct 30 - Nov 1 Comp Laude® Awards and Gala Manchester Grand Hyatt San Diego
Register Now!

Drugmakers Detail Barriers to Developing Non-Opioid Pain Meds

By Elaine Goodman (medical/business Reporter)

Tuesday, October 3, 2017 | 302 | 0 | 0 min read

A non-opioid drug that can help reduce or eliminate the need for opioids after surgery is not used as often as it could be because of Medicare’s method of reimbursement, a drug company official said. And because commercial payers often set their reimbursement based on Medicare policies, the issue is even more significant, noted Dave Stack, chief executive officer of Pacira Pharmaceuticals. Workers' comp fee schedules in many states are also based on Medicare rates. Pacira Pharmaceuticals makes a product called Exparel that’s sprayed into a surgical site, such as around t...

Purchase this story for only $9.16!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Be the first to comment.

Related Articles